ATS 2018 International Conference - Mobile

Impact of Body Mass Index on Efficacy of Benralizumab in Patients with Severe, Uncontrolled Eosinophilic Asthma: Pooled Analysis of the SIROCCO and CALIMA Trials [Board No. 412]

Location: Board no. 412

Session Type: RAPiD: Rapid Abstract Poster Discussion Session

Sunday

May

20

2:15 PM

4:15 PM

Speaker(s)/Author(s)

Frank Trudo

MD, MBA
AstraZeneca

Ubaldo J. Martin

MD
AstraZeneca

Ian Hirsch

PhD
AstraZeneca

Gokul Gopalan

MD,MPH
AstraZeneca

View Abstract

Impact of Body Mass Index on Efficacy of Benralizumab in Patients with Severe, Uncontrolled Eosinophilic Asthma: Pooled Analysis of the SIROCCO and CALIMA Trials

Parent Sessions

A101 - MECHANISMS AND CLINICAL FEATURES OF SEVERE ASTHMA...
05-20-2018 2:15 PM - 4:15 PM